Mounjaro is the first and only approved treatment in a different class of medication for type 2 diabetes.*

*It works differently than other type 2 diabetes medications by directly activating GIP and GLP-1 pathways to help regulate blood sugar.

GIP=glucose-dependent insulinotropic polypeptide; GLP-1=glucagon-like peptide-1.

What is Mounjaro? ||| h3

Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.

It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.

Mounjaro for type 2 diabetes

†In studies with or without other diabetes medications, the percentage of people taking Mounjaro who reached an A1C of less than 7% ranged from 75% (5 mg) to 90% (10 mg). People had an average starting A1C of 7.9% to 8.6% across the 5-mg, 10-mg, and 15-mg doses. A 40-week study was conducted to see if Mounjaro 5-mg, 10-mg, and 15-mg plus a basal insulin worked better than basal insulin people taking Mounjaro 10-mg plus basal insulin achieved an A1C of under 7%.

Select Safety Information

Mounjaro can cause serious side effects, including:
Inflammation of your pancreas (pancreatitis). Stop using Mounjaro and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.

Mounjaro is not a weight loss drug.

Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).

Select Safety Information

Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness, and feeling jittery.

See how Mounjaro did in studies ||| h3

Select Safety Information

Mounjaro can cause serious side effects, including: Inflammation of your pancreas (pancreatitis). Stop using Mounjaro and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.

Talk to your doctor about Mounjaro at your next visit

https://main--ewi-mounjaro-aem-us--elilillyco.aem.page/fragments/how-mounjaro-works-default

https://main--ewi-mounjaro-aem-us--elilillyco.aem.page/fragments/how-mounjaro-works-pzn

Take Mounjaro once a week ||| h3

Pick your day. ||| h5

Use Mounjaro 1 time each week, at any time of the day.

But we know schedules can change. If you want to change the day of the week you take your dose, make sure there are at least 3 days (72 hours) between doses.

If you miss a dose of Mounjaro, take the missed dose as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and take your next dose on the regularly scheduled day. Do not take 2 doses of Mounjaro within 3 days of each other.

It may be helpful to set a reminder in your phone so you don't forget which day is your Mounjaro day. If you set a reminder and decide to change your day, then don't forget to update your reminder to your new day.

Mounjaro comes in a single-dose pen that requires no mixing. ||| h4

There is no need to see or handle the needle.

Read the Instructions for Use included with your pen.

LEARN HOW TO USE

See how to use Mounjaro

Get all of the details in our video below and in the Instructions for Use.

https://main--ewi-mounjaro-aem-us--elilillyco.aem.page/fragments/mounjaro-savings-basic

Man smiling into camera

Getting the care you need can be quick and accessible

Explore speed, convenience, and access to focused care with independent telehealth or in-person providers through LillyDirect.

In-person care

Telehealth

LillyDirect® is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
PP-LX-US-0052 07/2024 ©Lilly USA, LLC 2024. All rights reserved.

https://main--ewi-mounjaro-aem-us--elilillyco.aem.page/fragments/quiz

https://main--ewi-mounjaro-aem-us--elilillyco.aem.page/fragments/sign-up